1. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
   Beatriz Aguilar-Bravo et al, 2023, Journal of Hepatology CrossRef
2. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway
   Shuhua Zhang et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
3. Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer
   Narmadhaa Siva et al, 2021, 3 Biotech CrossRef
4. Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
   Huimin Kong et al, 2021, Advanced Science CrossRef
5. Exosomes for CRISPR-Cas9 Delivery: The Cutting Edge in Genome Editing
   Cynthia Aslan et al, 2023, Molecular Biotechnology CrossRef
6. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management
   Khaled S Allemailem et al, 2023, International Journal of Nanomedicine CrossRef
7. CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections
   Ulyana I. Bartosh et al, 2023, International Journal of Molecular Sciences CrossRef
8. EMT signaling: potential contribution of CRISPR/Cas gene editing
   Reza Mohammadinejad et al, 2020, Cellular and Molecular Life Sciences CrossRef
9. Will CRISPR-Cas9 Have Cards to Play Against Cancer? An Update on its Applications
   Precilla S. Daisy et al, 2021, Molecular Biotechnology CrossRef
10. Vector engineering, strategies and targets in cancer gene therapy
    Vijayata Singh et al, 2022, Cancer Gene Therapy CrossRef
11. Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4
    Zhongrong Guo et al, 2019, International Journal of Molecular Medicine CrossRef
12. Interplays between non-coding RNAs and chemokines in digestive system cancers
    Abdollah Jafarzadeh et al, 2022, Biomedicine & Pharmacotherapy CrossRef
13. CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research
    Alejandro Martinez-Escobar et al, 2021, Frontiers in Oncology CrossRef
14. CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma
    Fahreddin Palaz et al, 2024, Journal of Hepatocellular Carcinoma CrossRef
15. Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma
    Xing Rong Guo et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
16. Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
    Khaled S. Allemailem et al, 2022, Cancer Communications CrossRef
17. Critical Steps in Epithelial-Mesenchymal Transition as Target for Cancer Treatment
    Evgeny V. Denisov et al, 2020, Approaching Complex Diseases CrossRef
18. CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
    Ruiting Li et al, 2022, Molecular Biomedicine CrossRef
19. Secretome of senescent hepatoma cells modulate immune cell fate by macrophage polarization and neutrophil extracellular traps formation
    Bijoya Sen et al, 2022, Medical Oncology CrossRef
20. Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma
    Ru Wang et al, 2022, Technology in Cancer Research & Treatment CrossRef
21. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
    Bin Liu et al, 2019, Drug Discovery Today CrossRef
22. CRISPR-Based Gene Editing: a Modern Approach for Study and Treatment of Cancer
    Pratik Talukder et al, 2024, Applied Biochemistry and Biotechnology CrossRef
23. Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease
    Sheng Wang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef